Based on 1 Wall Street analysts offering 12 month price targets for Biovica International AB Class B in the last 3 months. The average price target is kr1.00 with a high forecast of kr1.00 and a low forecast of kr1.00. The average price target represents a 41.28% change from the last price of kr0.71.

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

Highest Price Targetkr1.00

Average Price Targetkr1.00

Lowest Price Targetkr1.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

BIOVIC.B Analyst Recommendation Trends

Currently, no data available

Please return soon. This page is being updated.

Each month's total comprises the sum of three months' worth of ratings.

BIOVIC.B Financial Forecast

BIOVIC.B Earnings Forecast

Next quarter’s earnings estimate for BIOVIC.B is -kr0.11 with a range of -kr0.11 to -kr0.11. The previous quarter’s EPS was -kr0.21. BIOVIC.B beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.07% of the time in the same period. In the last calendar year BIOVIC.B has Outperformed its overall industry.

BIOVIC.B Sales Forecast

Next quarter’s sales forecast for BIOVIC.B is kr2.68M with a range of kr2.68M to kr2.68M. The previous quarter’s sales results were kr2.33M. BIOVIC.B beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.54% of the time in the same period. In the last calendar year BIOVIC.B has Preformed in-line its overall industry.

BIOVIC.B Stock Forecast FAQ

What is SE:BIOVIC.B’s average 12-month price target, according to analysts?

Based on analyst ratings, Biovica International AB Class B’s 12-month average price target is 1.00.

What is SE:BIOVIC.B’s upside potential, based on the analysts’ average price target?

Biovica International AB Class B has 41.28% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Biovica International AB Class B a Buy, Sell or Hold?

Biovica International AB Class B has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.

What is Biovica International AB Class B’s share price target?

The average share price target for Biovica International AB Class B is 1.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is kr1.00 ,and the lowest forecast is kr1.00. The average share price target represents 41.28% Increase from the current price of kr0.71.

What do analysts say about Biovica International AB Class B?

Biovica International AB Class B’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.

How can I buy shares of Biovica International AB Class B?

To buy shares of SE:BIOVIC.B, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing